Pulmonx Corporation
LUNG
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and preā¦ read more
Healthcare
Medical Devices
5 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$1.92
Price+6.08%
$0.11
1Y
Price
Market Cap
$78.233m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-58.2%
EBITDA Margin-63.6%
Net Profit Margin-16.6%
Free Cash Flow MarginRevenue
$90.549m
+8.1%
1y CAGR+19.4%
3y CAGR+17.2%
5y CAGREarnings
-$56.940m
-1.0%
1y CAGR+1.0%
3y CAGR-4.5%
5y CAGREPS
-$1.43
+0.7%
1y CAGR+3.4%
3y CAGR-1.9%
5y CAGRBook Value
$69.090m
$147.187m
Assets$78.097m
Liabilities$56.828m
DebtDebt to Assets
38.6%
-0.9x
Debt to EBITDAFree Cash Flow
-$31.979m
+3.1%
1y CAGR+11.5%
3y CAGR+7.9%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company